HUAPONT LIFE SCIENCES announced that it expects a net loss attributable to shareholders of the listed company of RMB 310 million to RMB 217 million for the period from January 1, 2024, to December 31, 2024, a decrease of 202.61% to 171.83% compared to the same period last year. The net loss after deducting non-recurring gains and losses is expected to be RMB 350 million to RMB 257 million, a decrease of 243.99% to 205.73% compared to the same period last year. The basic earnings per share loss is expected to be RMB 0.157 per share to RMB 0.1099 per share